Selected research
Industry Growth & Trends
Global Home Pet Deworming Medicine Industry Growth and Trends Forecast to 2032
Market perspective
The global Home Pet Deworming Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Home Pet Deworming Medicine include Zoetis, Merck & Co, Inc., Sava Healthcare Limited, Boehringer Ingelheim International GmbH, Ceva, Elanco, Virbac, PetIQ, LLC and Liquid Fence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Home Pet Deworming Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Home Pet Deworming Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Home Pet Deworming Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Home Pet Deworming Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Home Pet Deworming Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Home Pet Deworming Medicine Market by Company
Zoetis
Merck & Co, Inc.
Sava Healthcare Limited
Boehringer Ingelheim International GmbH
Ceva
Elanco
Virbac
PetIQ, LLC
Liquid Fence
Bird-X
HortiCentre
Green Gardener
The Big Cheese
Yorkshire Trading Company
Ramical
Beaphar
Agland
Home Pet Deworming Medicine Segment by Type
Internal Deworming
External Deworming
Home Pet Deworming Medicine Segment by Application
Cats
Dogs
Others
Home Pet Deworming Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Pet Deworming Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Pet Deworming Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Pet Deworming Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Home Pet Deworming Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Home Pet Deworming Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Internal Deworming
- External Deworming
Applications
- Cats
- Dogs
- Others
Companies covered
- Zoetis
- Merck & Co, Inc.
- Sava Healthcare Limited
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- Virbac
- PetIQ, LLC
- Liquid Fence
- Bird-X
- HortiCentre
- Green Gardener
- The Big Cheese
- Yorkshire Trading Company
- Ramical
- Beaphar
- Agland
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Home Pet Deworming Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Home Pet Deworming Medicine Sales Estimates and Forecasts (2021-2032)
- 1.3 Home Pet Deworming Medicine Market by Type
- 1.3.1 Internal Deworming
- 1.3.2 External Deworming
- 1.4 Global Home Pet Deworming Medicine Market Size by Type
- 1.4.1 Global Home Pet Deworming Medicine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Home Pet Deworming Medicine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Home Pet Deworming Medicine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Home Pet Deworming Medicine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Home Pet Deworming Medicine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Home Pet Deworming Medicine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Home Pet Deworming Medicine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Home Pet Deworming Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Home Pet Deworming Medicine Industry Trends
- 2.2 Home Pet Deworming Medicine Industry Drivers
- 2.3 Home Pet Deworming Medicine Industry Opportunities and Challenges
- 2.4 Home Pet Deworming Medicine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Home Pet Deworming Medicine Revenue (2021-2026)
- 3.2 Global Top Players by Home Pet Deworming Medicine Sales (2021-2026)
- 3.3 Global Top Players by Home Pet Deworming Medicine Price (2021-2026)
- 3.4 Global Home Pet Deworming Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Home Pet Deworming Medicine Major Company Production Sites & Headquarters
- 3.6 Global Home Pet Deworming Medicine Company, Product Type & Application
- 3.7 Global Home Pet Deworming Medicine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Home Pet Deworming Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Home Pet Deworming Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Home Pet Deworming Medicine Tier 1, Tier 2, and Tier 3
4 Home Pet Deworming Medicine Regional Status and Outlook
- 4.1 Global Home Pet Deworming Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Home Pet Deworming Medicine Historic Market Size by Region
- 4.2.1 Global Home Pet Deworming Medicine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Home Pet Deworming Medicine Sales in Value by Region (2021-2026)
- 4.2.3 Global Home Pet Deworming Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Home Pet Deworming Medicine Forecasted Market Size by Region
- 4.3.1 Global Home Pet Deworming Medicine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Home Pet Deworming Medicine Sales in Value by Region (2027-2032)
- 4.3.3 Global Home Pet Deworming Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Home Pet Deworming Medicine by Application
- 5.1 Home Pet Deworming Medicine Market by Application
- 5.1.1 Cats
- 5.1.2 Dogs
- 5.1.3 Others
- 5.2 Global Home Pet Deworming Medicine Market Size by Application
- 5.2.1 Global Home Pet Deworming Medicine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Home Pet Deworming Medicine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Home Pet Deworming Medicine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Home Pet Deworming Medicine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Home Pet Deworming Medicine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Home Pet Deworming Medicine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Home Pet Deworming Medicine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Home Pet Deworming Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zoetis
- 6.1.1 Zoetis Company Information
- 6.1.2 Zoetis Business Overview
- 6.1.3 Zoetis Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zoetis Home Pet Deworming Medicine Product Portfolio
- 6.1.5 Zoetis Recent Developments
- 6.2 Merck & Co, Inc.
- 6.2.1 Merck & Co, Inc. Company Information
- 6.2.2 Merck & Co, Inc. Business Overview
- 6.2.3 Merck & Co, Inc. Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck & Co, Inc. Home Pet Deworming Medicine Product Portfolio
- 6.2.5 Merck & Co, Inc. Recent Developments
- 6.3 Sava Healthcare Limited
- 6.3.1 Sava Healthcare Limited Company Information
- 6.3.2 Sava Healthcare Limited Business Overview
- 6.3.3 Sava Healthcare Limited Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sava Healthcare Limited Home Pet Deworming Medicine Product Portfolio
- 6.3.5 Sava Healthcare Limited Recent Developments
- 6.4 Boehringer Ingelheim International GmbH
- 6.4.1 Boehringer Ingelheim International GmbH Company Information
- 6.4.2 Boehringer Ingelheim International GmbH Business Overview
- 6.4.3 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Product Portfolio
- 6.4.5 Boehringer Ingelheim International GmbH Recent Developments
- 6.5 Ceva
- 6.5.1 Ceva Company Information
- 6.5.2 Ceva Business Overview
- 6.5.3 Ceva Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ceva Home Pet Deworming Medicine Product Portfolio
- 6.5.5 Ceva Recent Developments
- 6.6 Elanco
- 6.6.1 Elanco Company Information
- 6.6.2 Elanco Business Overview
- 6.6.3 Elanco Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Elanco Home Pet Deworming Medicine Product Portfolio
- 6.6.5 Elanco Recent Developments
- 6.7 Virbac
- 6.7.1 Virbac Company Information
- 6.7.2 Virbac Business Overview
- 6.7.3 Virbac Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Virbac Home Pet Deworming Medicine Product Portfolio
- 6.7.5 Virbac Recent Developments
- 6.8 PetIQ, LLC
- 6.8.1 PetIQ, LLC Company Information
- 6.8.2 PetIQ, LLC Business Overview
- 6.8.3 PetIQ, LLC Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 PetIQ, LLC Home Pet Deworming Medicine Product Portfolio
- 6.8.5 PetIQ, LLC Recent Developments
- 6.9 Liquid Fence
- 6.9.1 Liquid Fence Company Information
- 6.9.2 Liquid Fence Business Overview
- 6.9.3 Liquid Fence Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Liquid Fence Home Pet Deworming Medicine Product Portfolio
- 6.9.5 Liquid Fence Recent Developments
- 6.10 Bird-X
- 6.10.1 Bird-X Company Information
- 6.10.2 Bird-X Business Overview
- 6.10.3 Bird-X Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bird-X Home Pet Deworming Medicine Product Portfolio
- 6.10.5 Bird-X Recent Developments
- 6.11 HortiCentre
- 6.11.1 HortiCentre Company Information
- 6.11.2 HortiCentre Business Overview
- 6.11.3 HortiCentre Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 HortiCentre Home Pet Deworming Medicine Product Portfolio
- 6.11.5 HortiCentre Recent Developments
- 6.12 Green Gardener
- 6.12.1 Green Gardener Company Information
- 6.12.2 Green Gardener Business Overview
- 6.12.3 Green Gardener Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Green Gardener Home Pet Deworming Medicine Product Portfolio
- 6.12.5 Green Gardener Recent Developments
- 6.13 The Big Cheese
- 6.13.1 The Big Cheese Company Information
- 6.13.2 The Big Cheese Business Overview
- 6.13.3 The Big Cheese Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 The Big Cheese Home Pet Deworming Medicine Product Portfolio
- 6.13.5 The Big Cheese Recent Developments
- 6.14 Yorkshire Trading Company
- 6.14.1 Yorkshire Trading Company Company Information
- 6.14.2 Yorkshire Trading Company Business Overview
- 6.14.3 Yorkshire Trading Company Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Yorkshire Trading Company Home Pet Deworming Medicine Product Portfolio
- 6.14.5 Yorkshire Trading Company Recent Developments
- 6.15 Ramical
- 6.15.1 Ramical Company Information
- 6.15.2 Ramical Business Overview
- 6.15.3 Ramical Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Ramical Home Pet Deworming Medicine Product Portfolio
- 6.15.5 Ramical Recent Developments
- 6.16 Beaphar
- 6.16.1 Beaphar Company Information
- 6.16.2 Beaphar Business Overview
- 6.16.3 Beaphar Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Beaphar Home Pet Deworming Medicine Product Portfolio
- 6.16.5 Beaphar Recent Developments
- 6.17 Agland
- 6.17.1 Agland Company Information
- 6.17.2 Agland Business Overview
- 6.17.3 Agland Home Pet Deworming Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Agland Home Pet Deworming Medicine Product Portfolio
- 6.17.5 Agland Recent Developments
7 North America by Country
- 7.1 North America Home Pet Deworming Medicine Sales by Country
- 7.1.1 North America Home Pet Deworming Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Home Pet Deworming Medicine Sales by Country (2021-2026)
- 7.1.3 North America Home Pet Deworming Medicine Sales Forecast by Country (2027-2032)
- 7.2 North America Home Pet Deworming Medicine Market Size by Country
- 7.2.1 North America Home Pet Deworming Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Home Pet Deworming Medicine Market Size by Country (2021-2026)
- 7.2.3 North America Home Pet Deworming Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Home Pet Deworming Medicine Sales by Country
- 8.1.1 Europe Home Pet Deworming Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Home Pet Deworming Medicine Sales by Country (2021-2026)
- 8.1.3 Europe Home Pet Deworming Medicine Sales Forecast by Country (2027-2032)
- 8.2 Europe Home Pet Deworming Medicine Market Size by Country
- 8.2.1 Europe Home Pet Deworming Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Home Pet Deworming Medicine Market Size by Country (2021-2026)
- 8.2.3 Europe Home Pet Deworming Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Home Pet Deworming Medicine Sales by Country
- 9.1.1 Asia-Pacific Home Pet Deworming Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Home Pet Deworming Medicine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Home Pet Deworming Medicine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Home Pet Deworming Medicine Market Size by Country
- 9.2.1 Asia-Pacific Home Pet Deworming Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Home Pet Deworming Medicine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Home Pet Deworming Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Home Pet Deworming Medicine Sales by Country
- 10.1.1 South America Home Pet Deworming Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Home Pet Deworming Medicine Sales by Country (2021-2026)
- 10.1.3 South America Home Pet Deworming Medicine Sales Forecast by Country (2027-2032)
- 10.2 South America Home Pet Deworming Medicine Market Size by Country
- 10.2.1 South America Home Pet Deworming Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Home Pet Deworming Medicine Market Size by Country (2021-2026)
- 10.2.3 South America Home Pet Deworming Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Home Pet Deworming Medicine Sales by Country
- 11.1.1 Middle East and Africa Home Pet Deworming Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Home Pet Deworming Medicine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Home Pet Deworming Medicine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Home Pet Deworming Medicine Market Size by Country
- 11.2.1 Middle East and Africa Home Pet Deworming Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Home Pet Deworming Medicine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Home Pet Deworming Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Home Pet Deworming Medicine Value Chain Analysis
- 12.1.1 Home Pet Deworming Medicine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Home Pet Deworming Medicine Production Mode & Process
- 12.2 Home Pet Deworming Medicine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Home Pet Deworming Medicine Distributors
- 12.2.3 Home Pet Deworming Medicine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst